IMforte Study Results from ASCO 2025 & WCLC 2025 by Dr. Stephen Liu
Автор: OncUpdates: Latest Oncology Insights
Загружено: 2025-10-11
Просмотров: 546
Описание:
Dr. Stephen Liu goes over the ASCO 2025 and WCLC 2025 findings from the IMforte study which led to the approval of Lurbinectedin maintenance in combination with Atezolizumab for ES-SCLC. The study showed improvement in PFS and OS benefit.
Full Podcast: • IMforte - Maintenance Lurbinectedin + Atez...
Follow us on social media:
• X/Twitter: / oncbrothers
• Instagram: / oncbrothers
• Website: https://oncbrothers.com/
• Main Channel: / @oncologybrothers
Subscribe to our channel for more episodes!
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: